US Patent Issued to Board of Regents, The University of Texas System on July 15 for "Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer" (Texas Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,359,204, issued on July 15, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer" was invented by Mariano A. Garcia-Blanco (Galveston, Texas), Gaddiel Galarza-Munoz (Galveston, Texas) and Shelton S. Bradrick (Galveston, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes compositions and methods for treating an autoimmune disorder or a cancer in a subject in need thereof, the method comprising: administering an effective amount of a composition comprising an oligonucleotide that specifically bind...